Pain Research
For the past 20 years, Lilly has worked to develop treatments for people living with chronic or regular pain. Click the below button to learn more about pain research and clinical trials.
Learn MoreThe reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17.
Participants must have completed study H8H-MC-LAHX (NCT03988088) or study H8H-MC-LAHV (NCT number to be determined)
Participants must weigh at least 15 kilograms (kg)
Participants must not be pregnant or nursing
Participants must not have any acute, serious, or unstable medical condition
Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator
For the past 20 years, Lilly has worked to develop treatments for people living with chronic or regular pain. Click the below button to learn more about pain research and clinical trials.
Learn MoreWith the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.
Learn MoreLearn how Lilly is working with health care partners to improve diversity in our clinical studies.
Watch the VideoA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.